NOVAVAX INC (NVAX) Free cash flow 2016–2021
NOVAVAX INC (NVAX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$265.5MFY2021 · since FY2016: -$277.0M → $265.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $265.5M | +373.2% |
| FY2020 | -$97.2M | +29.8% |
| FY2019 | -$138.5M | +25.6% |
| FY2018 | -$186.2M | -25.2% |
| FY2017 | -$148.7M | +46.3% |
| FY2016 | -$277.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice